TGFB1 and neoplasm: Specifically, dysregulated TGF-β signals drive more aggressive tumor phenotypes supporting angiogenesis, infiltration, metastasis, immunosurveillance evasion, and epithelial-to-mesenchymal transition programs [159,160,161,162,163,164,165].